GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocGo Inc (NAS:DCGO) » Definitions » EPS (Diluted)

DocGo (DCGO) EPS (Diluted) : $0.28 (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is DocGo EPS (Diluted)?

DocGo's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was $0.05. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $0.28.

DocGo's EPS (Basic) for the three months ended in Sep. 2024 was $0.05. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was $0.29.

DocGo's EPS without NRI for the three months ended in Sep. 2024 was $0.05. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was $0.29.

During the past 12 months, DocGo's average EPS without NRIGrowth Rate was 216.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


DocGo EPS (Diluted) Historical Data

The historical data trend for DocGo's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocGo EPS (Diluted) Chart

DocGo Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
-0.20 -0.14 0.25 0.34 0.06

DocGo Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.07 0.10 0.06 0.05

Competitive Comparison of DocGo's EPS (Diluted)

For the Medical Care Facilities subindustry, DocGo's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DocGo's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocGo's PE Ratio distribution charts can be found below:

* The bar in red indicates where DocGo's PE Ratio falls into.



DocGo EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

DocGo's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(6.858-0)/105.618
=0.06

DocGo's Diluted EPS for the quarter that ended in Sep. 2024 is calculated as

Diluted EPS (Q: Sep. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(5.498-0)/106.291
=0.05

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DocGo  (NAS:DCGO) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


DocGo EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of DocGo's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


DocGo Business Description

Traded in Other Exchanges
N/A
Address
35 West 35th Street, Floor 6, New York, NY, USA, 10001
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company has three reportable segments: Mobile Health Services, Transportation Services, and Corporate. Mobile Health Services is the key revenue-generating segment for the company.
Executives
Michael J Burdiek director 39 PARKER, IRVINE CA 92618
Ely D Tendler director, officer: General Counsel, Secretary STRATEGIC AND LEGAL SERVICES, PLLC, 54 LAWRENCE AVENUE, LAWRENCE NY 11559
Lee Bienstock officer: Chief Operating Officer 35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Steven Katz director 20 REBEL RUN DR, EAST BRUNSWICK NJ 08816
Norman Rosenberg officer: CFO, Ambulnz Holdings, LLC 51 MOUNTAIN AVENUE, MONSEY NY 10952
Stephen Sugrue officer: Chief Compliance Officer 35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Anthony Capone officer: President 106 DUANE ST., #3, NEW YORK NY 10007
Adriaan Stephanus Oberholzer officer: Chief Financial Officer 35 W 35TH STREET, 6TH FLOOR, NEW YORK NY 10001
James M Travers director C/O FLEETMATICS, 1100 WINTER STREET, 4TH FL, WALTHAM MA 02451
Etalvina Leite director 5477 VIA NICOLA, NEWBURY PARK CA 91320
Stanley Vashovsky director, 10 percent owner, officer: Chief Executive Officer 763 RALEIGH STREET, WOODMERE NY 11598
Ira Smedra director 401 N. JUNE STREET, LOS ANGELES CA 90004
Mark Do Merlin officer: CMO, Ambulnz Holdings, LLC 35 W 35TH STREET, NEW YORK NY 10001
Michael S. Witkowski officer: Chief Compliance Officer PO BOX 10482, NEWBURGH NY 12552
Christopher Fillo director 3110 MAIN STREET, SUITE 310, SANTA MONICA CA 90405